1098 Once-Daily Versus Twice-Daily Mesalazine for Mild to Moderately Active Ulcerative Colitis: Mucosal Healing and Early Response Data From MOTUS, a Multicentre, Controlled, Randomised, Investigator-Blinded Study
- Resource Type
- Abstract
- Source
- In
Gastroenterology May 2012 142(5) Supplement 1:S - Subject
- Language
- ISSN
- 0016-5085